Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
1.093,811.096,521.100,221.091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
1.254,811.253,011.253,871.226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
1.761,111.764,271.766,881.744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
3.211,833.227,213.268,383.226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
1.474,521.479,031.481,041.466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
2.392,122.396,952.421,222.382,32
ALKEM:NSE
Alkem Laboratories Ltd
5.429,50 ₹
+1,60%
(+85,50) 1D
30 apr, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Açın
5.354,50 ₹
High
5.435,00 ₹
Low
5.291,00 ₹
Mkt. cap
645,65 mlrd
Avg. vol.
115,13K
Volume
151,87K
Dividend
0,94%
Quarterly dividend
12,75 ₹
Ex dividend date
14 fev 2025
P/E ratio
27,38
52-wk high
5.933,50 ₹
52-wk low
4.716,20 ₹
EPS
198,32 ₹
Shares outstanding
119,55 mln
No. of employees
19K
News stories
From sources across the web
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees18,8K
Founded1973
HeadquartersMumbay, Maxaraştra, Hindistan
SectorPharmaceutical industry
Last report
13 fev 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
56,88/ (57,97 est.)INR
-1,88%miss
Revenue / Estimate
37,37 mlrd/ (37,61 mlrd est.)INR
-0,64%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
31,44 mlrd
33,71 mlrd
40,01 mlrd
37,37 mlrd
Cost of goods sold
14,40 mlrd
11,71 mlrd
14,01 mlrd
12,73 mlrd
Cost of revenue
14,40 mlrd
11,71 mlrd
14,01 mlrd
12,73 mlrd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,05 mlrd
6,93 mlrd
7,10 mlrd
7,22 mlrd
Operating expense
14,28 mlrd
15,49 mlrd
17,73 mlrd
17,31 mlrd
Total operating expenses
28,68 mlrd
27,20 mlrd
31,74 mlrd
30,04 mlrd
Operating income
2,76 mlrd
6,51 mlrd
8,27 mlrd
7,33 mlrd
Other non operating income
-3,24 mlrd
1,36 mlrd
1,04 mlrd
1,43 mlrd
EBT including unusual items
3,96 mlrd
7,71 mlrd
8,95 mlrd
7,81 mlrd
EBT excluding unusual items
3,36 mlrd
7,58 mlrd
8,95 mlrd
8,33 mlrd
Income tax expense
733,30 mln
1,03 mlrd
1,16 mlrd
1,28 mlrd
Effective tax rate
18,53%
13,33%
12,98%
16,35%
Other operating expenses
-894,30 mln
7,68 mlrd
9,69 mlrd
9,15 mlrd
Net income
3,06 mlrd
6,64 mlrd
7,65 mlrd
6,36 mlrd
Net profit margin
9,73%
19,70%
19,12%
17,02%
Earnings per share
25,57
54,62
63,99
56,88
Interest and investment income
3,59 mlrd
-
-
-
Interest expense
-115,00 mln
-297,80 mln
-350,20 mln
-421,00 mln
Net interest expenses
3,47 mlrd
-297,80 mln
-350,20 mln
-421,00 mln
Depreciation and amortization charges
1,12 mlrd
876,80 mln
936,10 mln
950,10 mln
EBITDA
3,53 mlrd
7,29 mlrd
9,18 mlrd
8,11 mlrd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more